Warfarin Benefits Endure After Bioprosthetic Aortic Valve Replacement
Warfarin is recommended during the initial 3–6 months following surgical bioprosthetic valve replacement, regardless of position (aortic or mitral). Following transcatheter aortic valve implantation, the decision to select antiplatelet therapy or warfarin during the first 3–6 months should be ...
Warfarin has two different pregnancy categories depending on the presence of a mechanical heart valve. Warfarin was listed as a Category D drug for pregnant women with a mechanical heart valve and Category X for all other indications in pregnant women. Warfarin crosses the placental barrier, causing...
Apixaban versus warfarin for mechanical heart valve 颅thromboprophylaxis in a swine aortic heterotopic valve model. Arterio- scler Thromb Vasc Biol. 2017;37... PA Lester,DM Coleman,JA Diaz,... 被引量: 0发表: 2017年 Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE...
A total of 54.4% had mitral valve replacement (MVR), whereas 26.2% had aortic valve replacement (AVR). The mean TTR calculated using the Rosendaal method was 57.1%. There was no significant difference among patients with AVR, MVR, and both valves (AMVR) in terms of TTR (AVR vs. MVR ...
Aortic valve replacementOBJECTIVES. To assess if warfarin targeted to international normalized ratio (INR) 1.8 (range 1.5–2.0) is safe for all patients with an On-X aortic mechanical valve. METHODS. This prospective, observational registry follows patients receiving warfarin targeted at an INR of ...
Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacementChristina ChristerssonStefan K JamesLars LindhagenAnders AhlssonAnders Jeppsson
Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacementChristina ChristerssonStefan K JamesLars LindhagenAnders AhlssonAnders Jeppsson
undergo aortic valve replacement every year with majority of the patients opt for bioprosthetic rather than a mechanical prosthesis. He further adds that due to the elderly age and comorbid conditions of the patients leaves bioprosthetic valves as the only option as it eliminates the risk of ...
Merie C, Kober L, Skov Olsen P, Andersson C, Gislason G, Skov Jensen J et al. Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. JAMA 2012;308:2118-25....